The effects of antipsychotics on behavioral abnormalities of the Gunn rat (unconjugated hyperbilirubinemia rat), a rat model of schizophrenia

Asian Journal of Psychiatry

Volumn 6, Issue 2, 2013, Pages 119-123

  Tsuchie, Keiko ^a   Miyaoka, Tsuyoshi ^a   Furuya, Motohide ^a   Liaury, Kristian ^a   Ieda, Masa ^a   Wake, Rei ^a   Horiguchi, Jun ^a   Takechi, Mayumi ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Gunn rat; Prepulse inhibition (PPI); Schizophrenia; Unconjugated hyperbilirubinemia

Indexed keywords

ARIPIPRAZOLE; HALOPERIDOL; RISPERIDONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTISOCIAL BEHAVIOR; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DRUG EFFECT; GILBERT DISEASE; GUNN RAT; MALE; NONHUMAN; OPEN FIELD TEST; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SOCIAL BEHAVIOR; SOCIAL INTERACTION; TREATMENT RESPONSE;

ANIMALS; ANTIPSYCHOTIC AGENTS; DISEASE MODELS, ANIMAL; HALOPERIDOL; HYPERBILIRUBINEMIA; INHIBITION (PSYCHOLOGY); LOCOMOTION; MALE; NEUROPSYCHOLOGICAL TESTS; PIPERAZINES; QUINOLONES; RATS; RATS, GUNN; RISPERIDONE; SCHIZOPHRENIA; SOCIAL BEHAVIOR; STARTLE REACTION; TREATMENT OUTCOME;

EID: 84875371574     PISSN: 18762018     EISSN: 18762026     Source Type: Journal    
DOI: 10.1016/j.ajp.2012.09.007     Document Type: Article

References (33)

1. Arnold S.E., Trojanowski J.Q. Recent advances in defining the neuropathology of schizophrenia. Acta Neuropathologica 1996, 92:217-231.
2. Bach D.R., Kindler J., Strik W.K. Elevated bilirubin in acute and transient psychotic disorder. Pharmacopsychiatry 2010, 43:12-16.
3. Bosma P.J. Inherited disorders of bilirubin metabolism. Journal of Hepatology 2003, 38:107-117.
4. Braff D., Stone C., Callaway E., Glick I., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 1978, 15:339-343.
5. Braff L.D., Geyer A.M. Sensorimotor gating and schizophrenia. Human and animal model studies. Archives of General Psychiatry 1990, 47:181-188.
6. Burchell B., Hume R. Molecular genetic basis of Gilbert's syndrome. Journal of Gastroenterology and Hepatology 1999, 14:960-966.
7. Dalman C., Cullberg J. Neonatal hyperbilirubinemia - a vulnerability factor for mental disorder?. Acta Psychiatrica Scandinavica 1999, 100:469-471.
8. Delottorie D., Ruiz G., Brocard J., Schweitzer A., Roucard Y.R., Suand-Chagny M.F., Bressand K., Andrieux A. Chronic administration of antipsychotics improves behavioral and synaptic defects of STOP null mice. Psychopharmacology 2010, 208:131-141.
9. Fevery J. Pathogenesis of Gilbert's syndrome. European Journal of Clinical Investigation 1981, 11:417-418.
10. Gilbert A., Lereboulet P. La cholemie simple familale. La Semana Medica 1901, 21:241-243.
11. Grojean S., Koziel V., Vert P., Davel J.L. Bilirubin induces apoptosis via activation of NMDA receptors in developing rat brain. Experimental Neurology 2000, 166:334-341.
12. Gunn C.K. Hereditary acholuric jaundice in the rat. Canadian Medical Association Journal 1944, 50:230-237.
13. Hayashida M., Miyaoka T., Tsuchie K., Yasuda H., Wake R., Nishida A., Inagaki T., Toga T., Nagami H., Oda T., Horiguchi J. Hyperbilirubinemia-related behavioral and neuropathological changes in rats: a possible schizophrenia animal model. Progress in Neuropsychopharmacology and Biological Psychiatry 2009, 33:581-588.
14. Johnson L., Sarmiento F., Blanc W.A., Day R. Kernicterus in rats with an inherited deficiency of glucuronyl transferase. American Journal of Diseases of Children 1959, 97:591-608.
15. Johnson L., Garcia M.L., Figueroa E., Sarmiento F. Kernicterus in rats lacking glucuronyl transferase. American Journal of Diseases of Children 1961, 101:322-349.
16. Miyaoka T., Seno H., Maeda M., Itoga M., Horiguchi J. Schizophrenia-associated idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome): three case reports. Journal of Clinical Psychiatry 2000, 61:299-300.
17. Miyaoka T., Seno H., Itoga M., Iijima M., Inagaki T., Horiguchi J. Schizophrenia-associated idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). Journal of Clinical Psychiatry 2000, 61:868-871.
18. Miyaoka T., Seno H., Itoga M., Inagaki T., Horiguchi J. Structural brain changes in schizophrenia associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome): a planimetric CT study. Schizophrenia Research 2001, 52:291-293.
19. Miyaoka T., Yasukawa R., Mizuno S., Inagaki T., Horiguchi J. Clinical features of schizophrenia associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). International Journal of Psychiatry in Clinical Practice 2003, 7:199-203.
20. Miyaoka T., Horiguchi J. Schizophrenia and idiopathic hyperbilirubinemia (Gilbert's syndrome). Current Psychiatry Reviews 2005, 1:133-203.
21. Miyaoka T. Schizophrenia and idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). Journal of Brain Science 2005, 31:22-27.
22. Miyaoka T., Yasukawa R., Mihara T., Mizuno S., Yasuda H., Sukegawa T., Hayashida M., Inagaki T., Horiguchi J. Fluid-attenuated inversion-recovery MR imaging in schizophrenia associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). European Psychiatry 2005, 20:327-331.
23. 1H-MRS) of hippocampus, basal ganglia, and vermis of cerebellum in schizophrenia associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). Journal of Psychiatric Research 2005, 14:43-47.
24. Miyaoka T., Wake R., Hayashida M., Horiguchi J. Schizophrenia and idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). Central Nervous System Agents in Medical Chemistry 2008, 8:257-259.
25. Muller N., Schiller P., Ackenheil M. Coincidence of schizophrenia and hyperbilirubinemia. Pharmacopsychiatry 1991, 24:225-228.
26. Nabeshima T., Yamada K., Yamaguchi K., Hiramatsu M., Furukawa H., Kameyama T. Effect of lesions in the striatum, nucleus accumbens and medial raphe on phencyclidine-induced stereotyped behaviors and hyperactivity in rats. European Journal of Pharmacology 1983, 91:455-462.
27. Pearce I.A., Cambrey-Deakin M.A., Burgoyne R.D. Glutamate acting on NMDA receptors stimulates neurite outgrowth from cerebellar granule cells. FEBS Letters 1987, 223:143-147.
28. Rueter L.E., Ballard M.E., Gallagher K.B., Basso A.M., Curzon P., Kohlhaas K.L. Chronic low dose risperidone and clozapine alleviate positive but not negative symptoms in the rat neonatal ventral hippocampus lesion model of schizophrenia. Psychopharmacology 2004, 176:312-319.
29. Sams-Dodd F. Automation of the social interaction test by a video-tracking system: behavioural effects of repeated phencyclidine treatment. Journal of Neuroscience Methods 1995, 59:157-167.
30. Staay F.J., Arndt S.S., Nordquist R.E. Evaluation of animal models of neurobehavioral disorders. Behavioral and Brain Functions 2009, 5:11.
31. Sturgeon R.D., Fessler R.G., Meltzer H.Y. Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats. European Journal of Pharmacology 1979, 59:169-179.
32. 1H-MRS) of anterior cingulate gyrus, insular and thalamus in schizophrenia associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). Journal of Psychiatry and Neuroscience 2005, 30:416-422.
33. Wake R., Miyaoka T., Tsuchie K., Kawakami K., Nishida A., Inagaki T., Horiguchi J. Abnormalities in MRI signal intensity in schizophrenia associated with idiopathic unconjugated hyperbilirubinemia. Australian and New Zealand Journal of Psychiatry 2009, 43:1057-1069.